BEZALIP TAB 200MG 200 MG
BEZAFIBRATE : 200 MG · DIN 02084082 · HOFFMANN-LA ROCHE LIMITED
Health Canada status: CANCELLED POST MARKET
What is BEZALIP TAB 200MG?
BEZALIP TAB 200MG 200 MG contains BEZAFIBRATE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02084082, held by HOFFMANN-LA ROCHE LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 19-Jul-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02084082 |
|---|---|
| Brand name | BEZALIP TAB 200MG |
| Generic / active ingredient | BEZAFIBRATE : 200 MG |
| Manufacturer | HOFFMANN-LA ROCHE LIMITED |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AB02 BEZAFIBRATE |
| AHFS class | 24:06.06 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 19-Jul-2001 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C10AB02 BEZAFIBRATE. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BEZALIP SR | 400 MG | TABLET (EXTENDED-RELEASE) | ALLERGAN INC | MARKETED | DIN 02083523 |
| JAMP-BEZAFIBRATE SR | 400 MG | Tablet | JAMP PHARMA CORPORATION | MARKETED | DIN 02453312 |
| ACT-BEZAFIBRATE SR | 400 MG | TABLET (EXTENDED-RELEASE) | ACTAVIS GROUP PTC EHF | CANCELLED PRE MARKET | DIN 02379414 |
| PMS-BEZAFIBRATE | 200 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02240331 |
Who else supplies BEZAFIBRATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BEZAFIBRATE appears in 12 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.